Innovative therapeutics

Investors

SEC Filings

NASDAQBMRN
FormDescriptionDateFormat
8-KReport of unscheduled material events or corporate eventDec 23, 2004View HTMLDownload DOCDownload PDFDownload XLS
3Initial filing by director officer or owner of more than ten percent.Dec 23, 2004View HTMLDownload DOCDownload PDF
SC 13G/AAmendment to a previously filed SC 13GDec 17, 2004View HTMLDownload DOCDownload PDFDownload XLS
8-KReport of unscheduled material events or corporate eventDec 7, 2004View HTMLDownload DOCDownload PDFDownload XLS
4Statement of changes in beneficial ownership of securitiesDec 6, 2004View HTMLDownload DOCDownload PDF
4Statement of changes in beneficial ownership of securitiesDec 6, 2004View HTMLDownload DOCDownload PDF
4Statement of changes in beneficial ownership of securitiesDec 6, 2004View HTMLDownload DOCDownload PDF
4Statement of changes in beneficial ownership of securitiesDec 6, 2004View HTMLDownload DOCDownload PDF
4Statement of changes in beneficial ownership of securitiesDec 2, 2004View HTMLDownload DOCDownload PDF
4Statement of changes in beneficial ownership of securitiesDec 2, 2004View HTMLDownload DOCDownload PDF
8-KReport of unscheduled material events or corporate eventNov 30, 2004View HTMLDownload DOCDownload PDFDownload XLS
8-KReport of unscheduled material events or corporate eventNov 30, 2004View HTMLDownload DOCDownload PDFDownload XLS
8-KReport of unscheduled material events or corporate eventNov 24, 2004View HTMLDownload DOCDownload PDFDownload XLS
SC 13G/AAmendment to a previously filed SC 13GNov 16, 2004View HTMLDownload DOCDownload PDFDownload XLS
10-QQuarterly report which provides a continuing view of a company's financial positionNov 9, 2004View HTMLDownload DOCDownload PDFDownload XLS
8-KReport of unscheduled material events or corporate eventNov 3, 2004View HTMLDownload DOCDownload PDFDownload XLS
8-K/AAmendment to a previously filed 8-KOct 18, 2004View HTMLDownload DOCDownload PDFDownload XLS
10-Q/AAmendment to a previously filed 10-QOct 18, 2004View HTMLDownload DOCDownload PDFDownload XLS
8-KReport of unscheduled material events or corporate eventSep 21, 2004View HTMLDownload DOCDownload PDFDownload XLS
8-KReport of unscheduled material events or corporate eventAug 25, 2004View HTMLDownload DOCDownload PDFDownload XLS
8-KReport of unscheduled material events or corporate eventAug 24, 2004View HTMLDownload DOCDownload PDFDownload XLS
3Initial filing by director officer or owner of more than ten percent.Aug 23, 2004View HTMLDownload DOCDownload PDF
4Statement of changes in beneficial ownership of securitiesAug 23, 2004View HTMLDownload DOCDownload PDF
4Statement of changes in beneficial ownership of securitiesAug 20, 2004View HTMLDownload DOCDownload PDF
8-KReport of unscheduled material events or corporate eventAug 13, 2004View HTMLDownload DOCDownload PDFDownload XLS
1-25      26-50      51-75      76-78

BioMarin

Diseases

Lysosomal Storage Disorders (MPS I, MPS IVA, MPS VI, CLN2 disease) PKU, LEMS

Products

Brineura™
Vimizim®
Kuvan®
Naglazyme®
Aldurazyme®
Firdapse®

Patient/Physician Support Contact Information

BioMarin RareConnections
Tel: 866.906.6100
Fax: 888.863.3361
E-mail: support@biomarin-rareconnections.com

Global Medical Information

Contact Global Medical Information